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ABSTRACT: The preparation of shelf-stable crystalline salts of tert-
butylmethylphosphinous acid borane 1 is described. X-ray analysis of 
diisopropylammonium tert-butylmethylphosphinite borane 6 revealed the presence of a 
cyclic hydrogen-bond network in the solid state which accounts for an increased melting 
point and stability. Dialkylammonium phosphinite boranes are convenient precursors of 
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the chiral tert-butylmethylphosphine fragment. Compound 6 can be used directly in 
SN2@P reactions with various nucleophiles to yield valuable P-stereogenic intermediates 
and ligands.  
Since the initial seminal work of Knowles and co-workers,1 P-stereogenic phosphines 
have emerged as an important group of ligands that are highly proficient in asymmetric 
hydrogenation and other relevant industrial catalytic transformations.2,3 However, the 
assembly of stereogenic phosphorus centers in an optically pure fashion continues to be 
a hurdle. In this respect, the development of efficient methods for the rapid assembly of 
this class of compounds and the availability of key intermediates that facilitate the 
synthesis of P-stereogenic compounds is highly relevant in this field.  
Optically pure P-stereogenic phosphinous acid boranes are attractive synthetic 
intermediates in the synthesis of compounds with chiral phosphorus; however, they have 
received little attention. Buono and co-workers described the synthesis of several P-
stereogenic phosphinous acid boranes via H-menthylphosphinate or H-
adamantylphosphinate technology.4 Taking advantage of the intrinsic acidity of these 
compounds, Pietrusiewicz reported the resolution of several P-stereogenic phosphinous 
acid boranes via diastereomeric cinchonine salt formation.5  
We have recently achieved the efficient synthesis of optically pure tert-
butylmethylphosphinous acid-borane 1 (Scheme 1).6 This compound is a key P-
stereogenic intermediate in the synthesis of MaxPHOX and other ligands, which have 
shown excellent results in iridium- and rhodium-catalyzed asymmetric processes.7 The 
transformation of phosphinous acid 1 into optically pure tert-butylmethylphosphanamine 
2 allows its use in the synthesis of ligands such as MaxPHOS and SIP.8 It was also used 
as starting material for the preparation of optically pure tert-butylmethylphosphine-
borane 3 which is the precursor of Imamoto’s Quinox-P*.9 We firmly believe that 
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phosphinous acid 1 holds promise to become a key intermediate in the synthesis of new 
and already known P-stereogenic chiral ligands.  
The main drawback that hampers the extensive use of 1 is its limited stability. 
Phosphinous acid 1 is a gummy-solid with a low melting point (54-56ºC), which upon 
storage decomposes to yield the corresponding secondary phosphine oxide and borane 
byproducts. 1H NMR analysis revealed 35-40% of decomposition when a pure sample of 
1 was stored at room temperature for a week. This limited stability made it necessary to 
use 1 immediately after its preparation. This is clearly a serious drawback for the large-
scale utilization of 1.  
 
Scheme 1: Applications of optically pure tert-butylmethylphosphinous acid borane 1.  
 
With this scenario in mind, we considered that it would highly desirable to find a 
derivative of 1 that could circumvent the stability issues associated with pure phosphinous 
acid 1. Here we report on dialkylamonium phosphinites, which are stable and convenient 
surrogates of 1. These compounds are highly crystalline and can be utilized in the same 
fashion as 1 in SN2@P reactions with different nucleophiles to yield mono and 
bisphosphines in a stereospecific manner.  
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Figure 1: Melting points and stability of 1 and its corresponding ammonium 
phosphinites. 
The acidity of the phosphinous acid boranes is influenced by electronic and steric 
factors with pKa values ranging from 5.8 for Cy2P(BH3)OH to 3.9 for Ph2P(BH3)OH.10 
Potentiometric titration revealed that 1 has a pKa of 4.8 and thus should readily form salts 
with inorganic and organic bases (Figure 1). An initial assessment showed that sodium 
and potassium salts did not fulfill the requirements to become useful surrogates of 1 since 
they were hygroscopic and not crystalline. We then turned our attention to organic bases 
and various trialkyl and dialkyl amines, along with DMAP and DBU, were screened as 
salt formation agents. While triethylamine provided an oily salt (4), diethylamine 
afforded a crystalline solid (5) with a melting point of 151-153ºC. Diisopropylamine and 
dicyclohexylamine also provided crystalline salts 6 and 7 with melting points around 130-
140ºC. Most significantly, these saline surrogates proved to be shelf-stable and could be 
stored indefinitely at room temperature.  
To gain further insight into the high crystallinity of dialkylammonium derivatives of 1, 
an X-ray analysis of 6 was pursued. With this aim, single crystals were grown by 
evaporation of a solution of 6 in CH2Cl2. The resulting solid state structure of 6 is shown 
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in Figure 2. The resolved structure is pseudo-symmetric and holds a C2 axis of symmetry. 
The most characteristic feature is the cyclic hydrogen bond network that brings two 
tBuMeP(BH3)O– and two iPr2NH2+ units together in a tetrameric assembly. This cyclic 
H-bond network is completely planar. The two nitrogen and oxygen atoms conform a 
regular flat square of 2.77 Å sides. This strong hydrogen bond system probably accounts 
for the observed increased melting point (approx. +100ºC) with respect to the free 
phosphinous acid 1.  
 
 
Figure 2: X-ray structure of 6. Ortep diagram displays ellipsoids at 50% probability. Only 
hydrogen atoms involved in the H-bond network are depicted.  
 
With the stable dialkylammonium phosphonites in hand, we proceeded to test their 
ability to participate directly in SN2@P reactions (Table 1). We have recently developed 
a protocol for the activation of 1 with mesyl anhydride. This approach provides a mixed 
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anhydride that undergoes inversion of configuration when it reacts with different amine 
nucleophiles and reducing agents at -20ºC. For this test, we chose the optically pure 
diisopropylammonium phosphonite 6, since it contained a bulky amine that was not 
expected to participate as a nucleophile in the substitution reactions on phosphorus and 
offered the right balance between crystallinity and solubility. In practice, the addition of 
extra base was necessary to achieve clean activation of 6 with Ms2O. The use of 2 equiv. 
of NEt3 at -20ºC afforded the clean and fast formation of the mixed anhydride 
intermediate, which was then reacted in situ with the nucleophile of choice. Thus, reaction 
with ammonia afforded the resulting primary aminophosphine 2 in 98% ee (Table 1, entry 
1). Compound 2 is an intermediate in the synthesis of MaxPHOS ligand. Reduction of the 
mixed anhydride with Bu4NBH4 provided the secondary phosphine borane 3 in optically 
pure form and excellent yield (Table 1, entry 2). tert-Butylmethylphosphine borane 3 is 
also a key intermediate in the synthesis of Imamoto’s QuinoxP* and BenzP* ligands.11 
Reaction with primary amines provided the resulting SN2@P products with excellent 
yields and stereospecificity (Table 1, entries 3-6). Even for -branched chiral amines like 
(R)- and (S)-1-phenylethan-1-amine, the resulting substitution products 10 and 11 were 
obtained with almost perfect inversion of configuration at the phosphorus (Table 1, 
entries 5 and 6). Reaction with a highly functionalized amino alcohol produced solely the 
substitution product at the amine to give 12 in excellent yield as a single diastereomer, as 
determined by 1H NMR analysis (Table 1, entry 7). Compound 12 is a precursor of P-
stereogenic phosphino-oxazoline ligand MaxPHOX. The amenability of 6 for the 
synthesis of bis-aminophosphines was also studied. Indeed, reaction of 6 with 
ethylenediamine produced compound 13 in a single step in >95% diastereomeric excess 
and 66% yield (Table 1, entry 8). Also, using (R,R)-cyclohexane-1,2-diamine as 
nucleophile, the corresponding disubstitution product was readily isolated in satisfactory 
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yield and excellent optical and diastereomeric purity (Table 1, entry 9). Finally, 6 was 
reacted with diethylenetriamine, which bears one secondary and two primary amines 
(Table 1, entry 10). The SN2@P reaction proved highly specific for the primary positions 
and led to compound 15, which holds great potential as a wide bite-angle pincer ligand.  
 
Table 1: Reaction of 6 with various amine nucleophiles and reducing agents.  
 
Entry NuH Product  Yield (%)a ee/de
 
1 NH3 99 98% eeb 
2 Bu4N·BH4 80 99% eec 
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84 99% eed
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85 99% eed 
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88 98% dee 
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 NH
P
Me
tBu
BH3
Ph
11
83 98% dee 
7 H2N
iPr H
N
O
OH
iPr  
 
93 >95% dee 
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66 >95% dee 
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77 >95% dee 
10 
 
84 >95% dee 
a) Yield corresponds to isolated product purified by flash chromatography. b) 
Enantiomeric excess determined by chiral GC analysis. c) Enantiomeric excess 
determined by chiral HPLC of the corresponding benzyl derivative. d) Enantiomeric 
excess was determined by chiral HPLC. e) As determined by 1H NMR analysis.  
 
In summary, we disclosed that diisopropylammonium tert-butylmethylphosphonite 
borane 6 is a convenient highly crystalline and stable surrogate of the corresponding 
phosphinous acid. X-ray analysis showed that the increased stability of 6 in solid state 
arises from a tetrameric assembly with a cyclic H-bond network. Moreover, we have 
demonstrated that 6 can be used directly in SN2@P reactions with reducing agents and 
amine nucleophiles. We envisage that the stability of compounds 5-7 will foster the 
preparation and use of optically pure phosphinous acid boranes in large-scale in the 
synthesis of valuable P-stereogenic compounds.  
 
 
 
 
 
EXPERIMENTAL SECTION 
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General methods. All reactions were carried out in dried solvents under nitrogen 
atmosphere. Et2O and CH2Cl2 were dried in a purification system. Other commercially 
available reagents and solvents were used with no further purification. Thin layer 
chromatography was carried out using TLC-aluminum sheets with silica gel. Flash 
chromatography was performed by using an automated chromatographic system with 
hexane/ethyl acetate or hexane/dichloromethane gradients as eluent unless otherwise 
stated. NMR spectra were recorded at 23°C on a 400 MHz, 500 MHz or 600 MHz 
apparatus. 1H NMR and 13C{1H}NMR spectra were referenced either to relative internal 
TMS or to residual solvent peaks. 31P NMR spectra were referenced to phosphoric acid. 
Optical rotations were measured at room temperature (25°C) and concentration is 
expressed in g/100 mL. Melting points were determined using a Büchi apparatus and were 
not corrected. IR spectra were recorded in a FT-IR apparatus. HRMS were recorded in a 
LTQ-FT spectrometer using the Nanoelectrospray technique. Compound 1 was prepared 
from hydrolysis of the corresponding cis-hydroxyindan-1-yl derivative.6,12 
Diethylammonium (R)-tert-butyl(methyl)phosphinite borane (5). Phosphinous acid 
1 was placed in a vial (15 mg, 0.11mmol) and solved in TBME (0.5 mL). Diethylamine 
(12 L, 0.11 mmol) was added dropwise via a syringe. The resulting crystalline 
precipitate was filtered and dried under a stream of nitrogen. White solid. Yield: 87% (20 
mg). MP: 151 – 153ºC. [α]D: –22.1 (c 0.50, CHCl3). IR (KBr/NaCl) ʋmax: 3424, 2966, 
2349, 1628 and 997 cm-1. 1H NMR (400 MHz, CDCl3) δ; 9.08 (br s, 2H), 2.97 – 2.81 (m, 
4H), 1.33 (t, J = 7 Hz, 6H), 1.16 (d, JP = 8 Hz, 3H), 1.06 (d, JP = 13 Hz, 9H), 0.73 – 0.03 
(m, 3H, BH3) ppm. 13C{1H}NMR (101 MHz, CDCl3) δ; 42.4 (2 x CH2), 30.8 (d, JP = 41 
Hz, C), 24.6 (d, JP = 3 Hz, 3 x CH3), 13.8 (d, JP = 33 Hz, CH3), 12.0 (2 x CH3) 
ppm.31P{1H}NMR (202 MHz, CDCl3) δ; 90.1 – 87.9 (m, P–BH3). HRMS (ESI-TOF) m/z 
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[C4H12N]+ Calcd for C4H12N 74,0964; found 74.0965. HRMS (ESI-TOF) m/z 
[C5H15OBP]- Calcd for C5H15OBP 133.0959; found 133.0959. 
Diisopropylammonium (R)-tert-butyl(methyl)phosphinite borane (6). Phosphinous 
acid 1 was placed in a vial (15 mg, 0.11mmol) and solved in TBME (0.5 mL). 
Diisopropylamine (16 L, 0.11 mmol) was added dropwise via a syringe. The resulting 
crystalline precipitate was filtered and dried under a stream of nitrogen. White solid. 
Yield: 81% (21 mg). MP: 136.5 – 138.0ºC. [α]D: +3.2 (c 0.56, CHCl3). IR (KBr/NaCl) 
ʋmax: 3439, 2923, 2860, 2388 and 2342 cm-1. 1H NMR (400 MHz, CDCl3) δ; 7.43 (br s, 
1H), 3.27 – 3.16 (m, 2H), 1.29 (d, J = 6 Hz, 12H), 1.22 (d, JP = 9 Hz, 3H), 1.09 (d, JP = 
13 Hz, 9H), 0.79 – 0.01 (m, 3H, BH3) ppm. 13C{1H}NMR (101 MHz, CDCl3) δ 46.6 (2 
x CH), 30.9 (d, JP = 43 Hz, C), 24.6 (3 x CH3), 21.0 (d, JP = 11 Hz, 4 x CH3), 13.3 (d, JP 
= 35 Hz, CH3) ppm. 31P{1H}NMR (202 MHz, CDCl3) δ; 92.4 – 90.2 (m, P–BH3) ppm. 
HRMS (ESI-TOF) m/z [C6H16N]+ Calcd for C6H16N 102.1278; found 102.1277. HRMS 
(ESI-TOF) m/z [C5H15OBP]- Calcd for C5H15OBP 133.0959; found 133.0959.  
Dicyclohexylammonium (R)-tert-butyl(methyl)phosphinite borane (7). 
Phosphinous acid 1 was placed in a vial (15 mg, 0.11mmol) and solved in TBME (0.5 
mL). Dicyclohexylamine (22 L, 0.11 mmol) was added dropwise via a syringe. The 
resulting crystalline precipitate was filtered and dried under a stream of nitrogen. White 
solid. Yield: 87% (32 mg). MP: 143 – 144ºC. [α]D: +8.8 (c 0.34, CHCl3). IR (KBr/NaCl) 
ʋmax: 3419, 2939, 2857, 2347 and 1619 cm-1. 1H NMR (400 MHz, CDCl3) δ; 7.57 (br s, 
2H), 2.94 – 2.80 (m, 2H), 2.09 – 1.95 (m, 4H), 1.85 – 1.74 (m, 4H), 1.68 – 1.60 (m, 2H), 
1.51 – 1.33 (m, 4H), 1.31 – 1.12 (m, 6H), 1.20 (d, JP = 9 Hz, 3H), 1.08 (d, JP = 13 Hz, 
9H), 0.84–0.03 (m, 3H, BH3) ppm. 13C{1H}NMR (101 MHz, CDCl3) δ; 53.6 (2 x CH), 
31.4 – 31.2 (4 x CH2), 30.9 (d, JP = 43 Hz, C), 25.3 – 24.9 (6 x CH2), 24.6 (d, JP = 3 Hz, 
3 x CH3), 13.4 (d, JP = 36 Hz, CH3) ppm. 31P{1H}NMR (202 MHz, CDCl3) δ; 91.4 – 89.1 
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(m, P–BH3) ppm. HRMS (ESI-TOF) m/z [C12H24N]+ Calcd for C12H24N 182.1905; found 
182.1903.  HRMS (ESI-TOF) m/z [C5H15OBP]- Calcd for C5H15OBP 133.0959; found 
133.0959.  
General procedure for the substitution reactions with 6: Methanesulfonic anhydride 
(1.0 – 1.2 eq.) was solved in CH2Cl2 under N2 atmosphere and cooled to –20 ºC. A 
solution of the phosphinous acid salt 6 in CH2Cl2 under N2 atmosphere was slowly added 
dropwise. Anhydrous NEt3 (2.0 eq.) was then added dropwise. The reaction was stirred 
for 1.5 h at –20ºC. The corresponding amine/reducing agent (0.5 – 3 eq.) was added and 
the solution was stirred overnight at –20ºC. NaOH (1 M) was added to quench the reaction 
and the mixture was allowed to warm to room temperature. The mixture was extracted 
with CH2Cl2. The organic layer was washed with NaOH (1M) and/or HCl (1M) when 
deemed useful to purify the crude product. The organic layer was dried with MgSO4 and 
filtered, and the solvent was removed under reduced pressure. When required, the crude 
productwas further purified by flash chromatography (SiO2, hexanes:EtOAc).  
(+)-(S)-tert-butyl(methyl)phosphanamine borane (2).8a Following the general 
procedure, 73 mg of methanesulfonic anhydride (0.41 mmol, 1.2 eq.), 80 mg of 6 (0.34 
mmol, 1 eq.), 95 µL of NEt3 (0.68 mmol, 2 eq.) and 5 mL of CH2Cl2 were used. NH3 was 
bubbled through the solution for 5 min, then the flow was removed and the reaction stirred 
for 10 min. H2O was added to quench the reaction. The mixture was extracted with 
CH2Cl2 to afford 46 mg (99%, 0.34 mmol) of a white wax, which was not further purified 
(ee  98%). 1H NMR (400 MHz, CDCl3) δ; 1.76 (s, 2H), 1.35 (d, JP = 9 Hz, 3H), 1.14 (d, 
JP = 14 Hz, 9H), 0.86–0.08 (m, 3H, BH3) ppm. GC: β-DEX (30 m), 130ºC, 1 mL/min, 
tR(+) = 14.5 min, tR (–) = 14.9 min.  
(–)-(R)-tert-butyl(methyl)phosphine borane (3).13 Following the general procedure, 
128 mg of methanesulfonic anhydride (0.71 mmol, 1.05 eq), 160 mg of 6 (0.68 mmol, 1 
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eq), 150 µL of N-methylmorpholine (1.36 mmol, 2 eq) and 8 mL of CH2Cl2 were used. 
525 mg (2.04 mmol, 3 eq) of nBu4NBH4 in 2 mL of CH2Cl2 were added dropwise and the 
solution was stirred for 2 hours at –20ºC. NaOH (1 M) was added to quench the reaction. 
The mixture was extracted with CH2Cl2. This afforded, after purification by flash 
chromatography (SiO2, hexanes/EtOAc), 64 mg (80%, 0.54 mmol) of 3 as a white waxy 
solid (ee = 99%).14 1H NMR (400 MHz, CDCl3) δ; 4.40 (dm, JP = 355 Hz, 1H), 1.31 (dd, 
J = 11, 6 Hz, 3H), 1.21 (d, JP = 15 Hz, 9H), 0.48 (br q, JB = 96 Hz, 3H, BH3) ppm.  
(+)-(R)-1-tert-butyl-1-methyl-N-(pyridin-2-ylmethyl)phosphinamine borane (8).6 
Following the general procedure, 64 mg of methanesulfonic anhydride (0.36 mmol, 1.05 
eq), 80 mg of 6 (0.34 mmol, 1 eq.), 95 µL of NEt3 (0.68 mmol, 2 eq.) and 4 mL of CH2Cl2 
were used. 2-Picolylamine (105 µL, 1.02 mmol, 3 eq.) was added and the solution was 
stirred overnight at –20ºC. This afforded , 64 mg (84%, 0.29 mmol) of 8 as a white solid 
(ee = 99%) after purification by flash chromatography (SiO2, hexanes/EtOAc). 1H NMR 
(400 MHz, CDCl3) δ; 8.56 – 8.44 (m, 1H), 7.66 (td, J = 8, 2 Hz, 1H), 7.30 – 7.27 (m, 1H), 
7.21 – 7.15 (m, 1H), 4.42 – 4.30 (m, 1H), 4.30 – 4.19 (m, 1H), 2.80 (br s, 1H), 1.33 (d, JP 
= 9 Hz, 3H), 1.14 (d, JP = 14 Hz, 9H), 0.96–0.07 (m, 3H, BH3) ppm. HPLC: CHIRALCEL 
OJ. Heptane:EtOH: 90:10-0.2% DEA, 0.50 mL/min, λ= 210 nm. tR (–) = 12.9 min, tR (+) 
= 13.6 min.   
(–)-(S)-1-tert-butyl-1-methyl-N-(2-thiophenylmethyl)phosphinamine borane (9).6 
Following the general procedure, 64 mg of methanesulfonic anhydride (0.36 mmol, 1.05 
eq.), 80 mg of 6 (0.34 mmol, 1 eq.), 95 µL of NEt3 (0.68 mmol, 2 eq.) and 4 mL of CH2Cl2 
were used. 2-Thiophenemethylamine (105 µL, 1.02 mmol, 3 eq.) was added and the 
solution was stirred overnight at –20ºC. After purification by flash chromatography (SiO2, 
hexanes/EtOAc), 66 mg (85%, 0.29 mmol) of 9 as a white solid was obtained (ee = 99%). 
1H NMR (400 MHz, CDCl3) δ; 7.23 – 7.20 (m, 1H), 6.96 – 6.93 (m, 2H), 4.47 – 4.37 (m, 
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1H), 4.37 – 4.23 (m, 1H), 1.86 (br s, 1H), 1.36 (d, JP = 9 Hz, 3H), 1.15 (d, JP = 14 Hz, 
9H), 0.95 – 0.13 (m, 3H, BH3) ppm. HPLC: CHIRALCEL OJ. Heptane:EtOH: 80:20-
0.2% DEA, 0.50 mL/min, λ= 210 nm. tR (–) = 14.7 min, tR (+) = 15.9 min.  
(+)-(S)-1-tert-butyl-1-methyl-N-((R)-1-phenylethyl)phosphanamine borane (10).6 
Following the general procedure, 64 mg of methanesulfonic anhydride (0.36 mmol, 1.05 
eq.), 80 mg of 6 (0.34 mmol, 1 eq.), 95 µL of NEt3 (0.68 mmol, 2 eq.) and 4 mL of CH2Cl2 
were used. (R)-(1)-Phenylethylamine (132 µL, 1.02 mmol, 3 eq.) was added and the 
solution was stirred overnight at –20ºC. After purification by flash chromatography (SiO2, 
hexanes/EtOAc), 66 mg (83%, 0.28 mmol) of 10 as a white solid was obtained (de 98%, 
as determined by 1H NMR). 1H NMR (400 MHz, CDCl3) δ; 7.37 – 7.20 (m, 5H), 4.50 – 
4.41 (m, 1H), 1.81 (br d, J = 9 Hz, 1H)), 1.46 (d, J = 7 Hz. 3H), 1.24 (d, JP = 9 Hz, 3H), 
1.07 (d, JP = 14 Hz, 9H), 0.96–0.12 (m, 3H, BH3) ppm.  
(–)-(S)-1-tert-butyl-1-methyl-N-((S)-1-phenylethyl)phosphanamine borane (11).6 
Following the general procedure, 64 mg of methanesulfonic anhydride (0.36 mmol, 1.05 
eq), 80 mg of 6 (0.34 mmol, 1 eq.), 95 µL of NEt3 (0.68 mmol, 2 eq.) and 4 mL of CH2Cl2 
were used. (S)-(1)-Phenylethylamine (132 µL, 1.02 mmol, 3 eq.) were added and the 
solution was stirred overnight at –20ºC. The work-up afforded 70 mg (88%, 0.30 mmol) 
of 11 as a white solid which was not further purified (de 98%, as determined by 1H NMR). 
1H NMR (400 MHz, CDCl3) δ; 7.48 – 7.14 (m, 5H), 4.53 – 4.48 (m, 1H), 1.74 (br d, J = 
9 Hz, 1H)), 1.44 (d, J = 7 Hz. 3H), 1.20 (d, JP = 9 Hz, 3H), 1.11 (d, JP = 14 Hz, 9H), 
0.96–0.11 (m, 3H, BH3) ppm.  
(S)-2-(((S)-tert-butyl(methyl)phosphanyl)amino)-N-((S)-1-hydroxy-3-
methylbutan-2-yl)-3-methylbutanamide borane (12).7a Following the general 
procedure, 73 mg of methanesulfonic anhydride (0.41 mmol, 1.2 eq.), 80 mg of 6 (0.34 
mmol, 1 eq.), 95 µL of NEt3 (0.68 mmol, 2 eq.) and 4 mL of CH2Cl2 were used. (S)-2-
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Amino-N-((S)-1-hydroxy-3-methylbutan-2-yl)-3-methylbutanamide (206 mg, 1.02 
mmol, 3 eq.) was added and the solution was stirred overnight at –20ºC. Work-up and 
purification by flash chromatography (SiO2, hexanes/EtOAc) afforded 96 mg (93%, 0.32 
mmol) of 12 as a white solid. (de >95%, as determined by 1H NMR). 1H NMR (400 MHz, 
CDCl3) δ; 6.13 (br s, 1H), 3.77 – 3.64 (m, 3H), 3.49 (ddd, J = 11, 9, 7 Hz, 1H), 2.21 (dd, 
J = 11, 5 Hz, 1H), 2.01 – 1.84 (m, 2H), 1.27 (d, JP = 9 Hz, 3H), 1.15 (d, JP = 14 Hz, 9H), 
1.01 – 0.95 (m, 12H), 0.81 – 0.06 (m, 3H, BH3) ppm.  
(S,S)-N1,N2-bis(tert-butyl(methyl)phosphanyl)ethane-1,2-diamine bisborane (13). 
Following the general procedure, 128 mg of methanesulfonic anhydride (0.71 mmol, 1.05 
eq.), 160 mg of 6 (0.68 mmol, 1 eq.), 189 µL of NEt3 (1.36 mmol, 2 eq.) and 10 mL of 
CH2Cl2 were used. Ethylenediamine (18 µL, 0.27 mmol, 0.4 eq.) were added and the 
solution was stirred overnight at –20ºC. This afforded, after purification by flash 
chromatography (SiO2, hexanes/EtOAc), 52 mg (66%, 0.18 mmol) of 13 as a white solid. 
(de >95%, as determined by 1H NMR). Mp: 123.5 – 124.5ºC. [α]D: +6.7 (c 0.23, CHCl3). 
IR (KBr/NaCl) ʋmax: 3335, 2970, 2390, 2345 and 1467 cm-1. 1H NMR (400 MHz, CDCl3) 
δ; 3.16 – 2.97 (m, 4H), 1.68 (br s, 2H), 1.33 (d, J = 9 Hz, 6H), 1.12 (d, J = 14 Hz, 18H), 
0.86–0.05 (m, 6H, 2 x BH3) ppm. 13C{1H}NMR (101 MHz, CDCl3) δ; 45.3 (d, J = 5 Hz, 
2 x CH2), 31.2 (d, J = 39 Hz, 2 x C), 24.7 (d, J = 3 Hz, 6 x CH3), 9.6 (d, J = 40 Hz, 2 x 
CH3) ppm. 31P{1H}NMR (202 MHz, CDCl3) δ; 72.3 – 70.0 (m, 2 x P–BH3) ppm. HRMS 
(ESI-TOF) m/z [C12H36B2N2P2 + H]+ Calcd for C12H37B2N2P2 293.2609; found 293.2613.  
(1R,2R)-N1,N2-bis((S)-tert-butyl(methyl)phosphanyl)cyclohexane-1,2-diamine 
bisborane (14). Following the general procedure, 99 mg of methanesulfonic anhydride 
(0.55 mmol, 1 eq.), 130 mg of 6 (0.55 mmol, 1 eq.), 154 µL of NEt3 (1.11 mmol, 2 eq.) 
and 6 mL of CH2Cl2 were used. (1R,2R)-Cyclohexane-1,2-diamine (28 mg, 0.25 mmol, 
0.45 eq.) were added dissolved in 3 mL of CH2Cl2 and the solution was stirred overnight 
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at –20ºC. This afforded 78 mg (91%, 0.23 mmol) of a very pure solid crude. After further 
purification by column chromatography (SiO2, hexanes/EtOAc), 66 mg (77%, 0.19 
mmol) of 14 was obtained as a white solid. (de >95%, as determined by 1H NMR). MP: 
216.5 – 217.5ºC. [α]D: –3.9 (c 0.39, CHCl3). IR (KBr/NaCl) ʋmax: 3305, 2926, 2362, 2339 
and 1096 cm-1. 1H NMR (400 MHz, CDCl3) δ; 2.91 (br s, 2H), 2.12 (br d, J = 13 Hz, 2H), 
1.68 – 1.52 (m, 4H), 1.36 – 1.13 (m, 4H), 1.33 (d, J = 9 Hz, 6H), 1.16 (d, J = 14 Hz, 18H), 
0.84–0.03 (m, 6H, 2 x BH3) ppm. 13C{1H}NMR (101 MHz, CDCl3) δ; 57.8 (d, J = 7 Hz, 
2 x CH), 36.1 (CH2), 30.1 (d, J = 44 Hz, C), 24.7 (d, J = 3 Hz, 6 x CH3), 24.4 (4 x CH2), 
11.8 (d, J = 32 Hz, 2 x CH3) ppm. 31P{1H}NMR (202 MHz, CDCl3) δ; 70.8 – 69.0 (m, 2 
x P–BH3) ppm. HRMS (ESI-TOF) m/z [C16H42B2N2P2 + Na]+ Calcd for C16H42B2N2P2Na 
369.2907; found 369.2902.  
N1-((S)-tert-butyl(methyl)phosphanyl)-N2-(2-(((S)-tert-butyl(methyl)phosphanyl) 
amino) ethyl)ethane-1,2-diamine  bisborane (15). Following the general procedure, 
128 mg of Ms2O (0.71 mmol, 1 eq.), 168 mg of 6 (0.71 mmol, 1 eq.), 199 µL of NEt3 
(1.42 mmol, 2 eq.) and 10 mL of CH2Cl2 were used. Diethylenetriamine (35 µL, 0.32 
mmol, 0.45 eq.) was added and the solution was stirred overnight at –20ºC. This afforded, 
after purification by column chromatography (SiO2, hexanes/EtOAc), 92 mg (84%) of 15 
as a yellow wax. (de >95%, as determined by 1H NMR). [α]D: +11.4 (c 0.54, CHCl3). IR 
(KBr) ʋmax: 3353, 2928, 2866, 2364 and 2337 cm-1. 1H NMR (400 MHz, CDCl3) δ; 3.15 
– 3.05 (m, 2H), 3.05 – 2.96 (m, 2H), 2.71 – 2.66 (m, 4H), 2.03 (br t, J = 6 Hz, 2H), 1.95 
(br s, 1H), 1.30 (d, J = 9 Hz, 6H), 1.11 (d, J = 14 Hz, 18H), 0.86–0.03 (m, 6H, 2 x BH3) 
ppm. 13C{1H}NMR (101 MHz, CDCl3) δ; 50.8 (d, J = 5 Hz, 4 x CH2), 42.8 (4 x CH2), 
31.2 (d, J = 39 Hz, C), 24.8 (d, J = 3 Hz, 6 x CH3), 9.28 (d, J = 39 Hz, 2 x CH3) ppm. 
31P{1H}NMR (202 MHz, CDCl3) δ; 70.7 – 68.9 (m, 2 x P–BH3) ppm. HRMS (ESI-TOF) 
m/z [C14H41B2N3P2 + H]+ Calcd for C14H42B2N3P2 336.3034; found 336.3035. 
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